Campaign Blog

Facing His First Primary Challenge in Six Years, Rep. Auchincloss Finally Cosponsors a Constitutional Amendment to Overturn Citizens United

After sixteen months of declining to cosponsor any of the four pending amendments, the congressman signed onto one the day after his office defended his record on the issue to Fig City News.

May 24, 2026

For sixteen months, Rep. Auchincloss had not cosponsored any of the four pending constitutional amendments to overturn Citizens United. A Fig City News profile of our campaign noted the gap; his office responded; the next day, the cosponsorship was filed.

Solana's CEO Wrote Auchincloss a Maximum Check — Months After Auchincloss Voted to Strip SEC Oversight of Solana

$10,500 from Solana Labs' CEO and COO Arrived Months After the Congressman Publicly Demanded a Memecoin Investigation

April 19, 2026

Auchincloss publicly criticized Trump's Solana-based memecoin grift. Then he voted for the bill that hands Solana the regulatory framework it has been lobbying for. Then Solana's CEO and COO maxed out to his campaign on the same day.

Palantir Built ICE's Surveillance Machine — And Its Executives Are Funding Rep. Auchincloss

$25,350 from Palantir's CEO, CFO, and Senior Executives Has Flowed to Auchincloss in 2025

January 30, 2026

Palantir Technologies has received nearly a billion dollars in federal contracts to build the surveillance infrastructure that powers ICE's enforcement operations. Its executives — including CEO Alexander Karp — have contributed $25,350 to Rep. Auchincloss's campaign.

How the Israel Lobby Became Rep. Auchincloss's Top Campaign Funder

$1.09 Million+ in Pro-Israel Money Has Flowed to Jake Auchincloss Since 2020

January 17, 2026

AIPAC-connected money is now Rep. Jake Auchincloss's single largest source of campaign funds. The same billionaires funding his campaigns have poured over $230 million into electing Donald Trump.

How Pharmaceutical Industry Money Blocks Congressional Drug Price Reform

$1.16 Million in Pharma Money Bought Jake Auchincloss and an $8.8 Billion Congressional Giveaway

January 17, 2026

The pharmaceutical industry’s investment in American politics delivers extraordinary returns. After a secret $4 million dark-money donation from PhRMA to the Republican-aligned American Action Network, drugmakers recently secured $8.8 billion in savings over the next decade through GOP-led rollbacks of drug price negotiation provisions in the “One Big Beautiful Bill”...

Pharma's Playbook: How Auchincloss Adopted Big Drug's Talking Points on Pharmacy Benefit Manager Reform

Rep. Auchincloss's PBM bill uses the same language pharmaceutical manufacturers use to deflect blame for the prices they set.

December 26, 2025

Auchincloss's PBM bill borrows the same buzzwords — 'middlemen,' 'transparency,' 'patient costs at the counter' — that PhRMA has spent millions promoting.

Rep. Auchincloss Criticizes Citizens United But Won't Cosponsor Any of the Four Pending Amendments to Overturn It

December 16, 2025

Auchincloss calls Citizens United a threat to democracy in his newsletter—but won't put his name on any of the four constitutional amendments to fix it. Follow the money to understand why.

Six Weeks After Shireen Abu Akleh's Killing: Rep. Auchincloss Accepts $24,000 Trip from AIPAC's Charitable Arm

December 13, 2025

In late June 2022, Rep. Jake Auchincloss and his wife Michelle boarded a flight to Israel, their travel fully funded by the American Israel Education Foundation.1 The week-long trip, which ran from June 26 to July 2, came just six weeks after Israeli forces killed Palestinian-American journalist Shireen Abu Akleh...

The Blockchain Eight: How Rep. Auchincloss Became Crypto's Man in Congress

From Personal Investments to Policy Favors, Auchincloss Has Consistently Delivered for the Cryptocurrency Industry

December 09, 2025

The IRS can track your Venmo transactions, but Rep. Auchincloss voted to let DeFi platforms traffic billions in unreported crypto trades. Follow the money to understand why.

The Auchincloss Influence Machine: How One Biotech Firm Built a Policy Pipeline

RA Capital, No Patient Left Behind, and Rep. Jake Auchincloss: A Case Study in Corporate Policy Capture

December 01, 2025

In our previous investigation, we documented how Rep. Jake Auchincloss received over $815,000 from pharmaceutical industry sources from 2020-2024. One donor network stands out for its sophistication: RA Capital Management, a Boston-based biotech venture capital firm that has constructed an influence machine connecting campaign contributions, policy research, and legislative outcomes...

What the Largest Basic Income Study in American History Found

Researchers gave 1,000 low-income adults in Texas and Illinois $1,000 per month with no conditions. The results show promise for UBI proposals.

November 25, 2025

The OpenResearch Unconditional Cash Study — the largest randomized controlled trial of unconditional cash transfers in American history — released three years of data in 2024. The study offers the most rigorous evidence to date on what happens when you give low-income Americans money with no strings attached.